Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: A five-year model to assess the early cost-effectiveness of new diagnostic tests in the early diagnosis of rheumatoid arthritis

Fig. 3

Cost-effectiveness acceptability curves for add-on for the intermediate-risk test strategy and the current diagnostic test strategy. Current test strategy = American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) 2010 rheumatoid arthritis (RA) classification criteria. QALY quality-adjusted life year, MRI magnetic resonance imaging

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us